Literature DB >> 16136463

Lung remodeling in pulmonary tuberculosis.

Keertan Dheda1, Helen Booth, Jim F Huggett, Margaret A Johnson, Alimuddin Zumla, Graham A W Rook.   

Abstract

Tuberculosis is a global public health catastrophe responsible for >8 million cases of illness and 2 million deaths annually. Pulmonary cavitation with cough-generated aerosol is the principle means of spread, and lung remodeling (healed cavitation, fibrosis, and bronchiectasis) is a major cause of lung disability, surpassing all other diffuse parenchymal lung diseases combined. Efficient granuloma turnover is mycobactericidal, and extracellular matrix is disbanded without scarring. In many with progressive disease, however, there is dysregulated granuloma turnover, liquefactive necrosis, and pathological scarring. The pathological mechanisms and the related immunological pathways underpinning these phenomena are reviewed in the present article. Further studies are needed to identify and develop specific immunotherapeutic interventions that target immunopathology, since they have the potential to substantially reduce spread.

Entities:  

Mesh:

Year:  2005        PMID: 16136463     DOI: 10.1086/444545

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  85 in total

1.  Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.

Authors:  Jia Yao Phuah; Joshua T Mattila; Philana L Lin; JoAnne L Flynn
Journal:  Am J Pathol       Date:  2012-06-19       Impact factor: 4.307

3.  Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.

Authors:  Umi Hani' Vismayanti Lismana; Afiono Agung Prasetyo
Journal:  J Clin Diagn Res       Date:  2015-09-01

4.  Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol.

Authors:  Randall J Basaraba; Erin E Smith; Crystal A Shanley; Ian M Orme
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

Review 5.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 6.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

7.  Clinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.

Authors:  Avradip Santra; Pravati Dutta; Rekha Manjhi; Sudarsan Pothal
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Inorganic arsenic as a developmental toxicant: in utero exposure and alterations in the developing rat lungs.

Authors:  Jay S Petrick; Francoise M Blachere; Ornella Selmin; Robert Clark Lantz
Journal:  Mol Nutr Food Res       Date:  2009-05       Impact factor: 5.914

9.  The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.

Authors:  Bintou A Ahidjo; Mariama C Maiga; Elizabeth A Ihms; Mamoudou Maiga; Alvaro A Ordonez; Laurene S Cheung; Sarah Beck; Bruno B Andrade; Sanjay Jain; William R Bishai
Journal:  JCI Insight       Date:  2016-09-08

Review 10.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.